9th Feb 2023 20:25
Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Raises gross proceeds of around USD6.0 million through the issue of 10.3 million units at an issue price of USD0.58 per unit. One unit either includes one American depository share, one A warrant and one and one-half B warrant, or one pre-funded warrant, one A warrant and one and one-half B warrant. Says that the net proceeds will enable the company to focus on developing MTX110, its clinical asset, and provide it with sufficient working capital until December 2023.
Current stock price: 2.10 pence
12-month change: down 86%
By Abby Amoakuh, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.